Our Pricing

Weight Loss Injections: NHS Alternative Options in the UK

Published on: June 03, 2026

Seeking weight loss injections NHS alternative UK options? At Cured Pharmacy, you can access the same clinically proven GLP-1 treatments — Mounjaro, Wegovy, and Saxenda — through our UK-registered prescribers, with transparent pricing from £135.00 and discreet home delivery. Our online service provides a convenient alternative when NHS waiting lists are lengthy or eligibility criteria aren't met.

Understanding Weight Loss Injections as an NHS Alternative

Weight loss injections containing GLP-1 receptor agonists are now licensed in the UK for chronic weight management, but NHS availability remains limited by strict eligibility criteria and regional prescribing variations [1]. Private online pharmacies like Cured Pharmacy offer a regulated alternative pathway, providing the same MHRA-licensed medications through remote clinical assessments conducted by UK-registered prescribers.

The three main injectable treatments available are tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda). Each works by mimicking natural hormones that regulate appetite and blood sugar, but they differ in potency, dosing frequency, and clinical outcomes [1][2]. All require prescription-only access in the UK and must be prescribed following a comprehensive medical assessment.

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription to ensure clinical appropriateness and patient safety. Our service includes free online consultation, genuine UK-licensed medicines, and ongoing support throughout your treatment journey.

Mounjaro (Tirzepatide): The Dual-Action Weight Loss Injection

Mounjaro represents the latest advancement in weight loss pharmacotherapy, containing tirzepatide — the first dual GIP/GLP-1 receptor agonist licensed by the MHRA [1]. Unlike single-pathway treatments, tirzepatide activates two complementary hormone systems that regulate appetite, food intake, and glucose metabolism, producing superior weight reduction in clinical trials.

In the SURMOUNT-1 trial, participants receiving the highest tirzepatide dose achieved an average 22.5% body weight reduction over 72 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight losses observed in any pharmacological obesity trial to date. The once-weekly injection schedule offers convenience, with doses gradually escalated to minimise gastrointestinal side effects.

At Cured Pharmacy, Mounjaro is available from £135.00 following clinical approval by a UK prescriber. The treatment requires subcutaneous injection once weekly using the pre-filled KwikPen device, which most patients find straightforward after initial guidance.

Who Can Use Mounjaro?

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [3]. During your free online consultation, our UK prescribers assess your medical history, current medications, and weight management goals to determine suitability. Certain conditions — including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease — may preclude treatment.

Wegovy (Semaglutide): Proven Weight Loss Results

Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied in the STEP clinical trial programme [2]. In the pivotal STEP 1 trial, participants achieved an average 14.9% body weight reduction over 68 weeks, significantly higher than the 2.4% seen with placebo [2]. The medication works by reducing appetite, slowing gastric emptying, and enhancing feelings of fullness after meals.

The once-weekly subcutaneous injection is administered using a pre-filled pen, with doses gradually increased over 16-20 weeks to reach the maintenance dose of 2.4mg weekly. This titration schedule helps minimise common gastrointestinal side effects such as nausea and diarrhoea, which typically diminish as the body adapts to treatment [2].

Cured Pharmacy offers Wegovy from £135.00 representing competitive UK pricing for this MHRA-licensed treatment. All prescriptions are subject to clinical assessment by our UK-registered prescribers, ensuring the medication is appropriate for your individual circumstances.

Wegovy Dosing and Administration

Treatment begins with a 0.25mg weekly dose, gradually increasing every four weeks through 0.5mg, 1mg, and 1.7mg before reaching the maintenance dose of 2.4mg weekly. This step-wise approach allows your body to adjust to the medication's effects whilst minimising side effects. Our prescribers provide detailed injection technique guidance, and the pre-filled pens are designed for straightforward self-administration at home.

Saxenda (Liraglutide): Daily Weight Management Injection

Saxenda contains liraglutide, a GLP-1 receptor agonist administered as a daily subcutaneous injection rather than weekly dosing [4]. In the SCALE clinical trial programme, participants achieved an average 8% body weight reduction over 56 weeks when combined with reduced-calorie diet and increased physical activity [4]. Whilst the weight loss magnitude is generally lower than newer agents like tirzepatide and high-dose semaglutide, Saxenda remains a valuable option for certain patients.

The daily injection schedule provides consistent appetite suppression throughout the day, which some patients prefer for maintaining steady control over food intake. The starting dose of 0.6mg is gradually increased over five weeks to the maintenance dose of 3mg daily, helping to minimise gastrointestinal side effects during initiation [4].

Available from £135.00 at Cured Pharmacy, Saxenda offers an accessible entry point for weight loss injection therapy. The pre-filled pen device contains multiple doses and includes dose-selector functionality for accurate administration.

Oral Weight Loss Medications: Non-Injectable Alternatives

For patients who prefer not to use injections, oral weight loss medications provide effective alternatives. Orlistat (available as prescription-strength 120mg capsules or lower-dose 60mg formulations like Alli and Orlos) works by blocking approximately 30% of dietary fat absorption in the intestines [5]. Unlike GLP-1 treatments that affect appetite signalling, orlistat requires adherence to a reduced-fat diet to minimise gastrointestinal side effects.

Clinical trials demonstrate that orlistat 120mg three times daily produces an average 2.9kg greater weight loss compared to placebo over one year when combined with lifestyle modifications [5]. The medication is particularly suitable for patients with contraindications to GLP-1 therapies or those seeking a non-systemic treatment option that works locally in the digestive tract.

Cured Pharmacy stocks prescription Orlistat from £135.00 branded Xenical from £135.00, and over-the-counter Alli (60mg) and Orlos (60mg) from £135.00. We've also introduced pre-orders for Wegovy® oral tablets (semaglutide pill) from £10 offering the benefits of GLP-1 therapy without injections once this formulation receives UK marketing authorisation.

Choosing Between Injectable and Oral Treatments

Your choice between injectable GLP-1 medications and oral alternatives depends on multiple factors including weight loss goals, medical history, injection tolerance, and budget considerations. Injectable GLP-1 treatments generally produce greater weight reduction but require subcutaneous administration and carry higher costs. Oral medications like orlistat offer convenience and lower pricing but typically yield more modest results. During your consultation, our UK prescribers discuss these options to identify the most appropriate treatment for your circumstances.

How to Access Weight Loss Injections Through Cured Pharmacy

Accessing weight loss injections as an NHS alternative through Cured Pharmacy involves a straightforward four-step process. First, complete our free online medical consultation, which takes under three minutes and covers your medical history, current medications, weight management goals, and any contraindications. This assessment is reviewed by a UK-registered prescriber who determines whether treatment is clinically appropriate for you.

If approved, your prescription is electronically transmitted to our GPhC-registered pharmacy (registration number 9012511) where our team dispenses your medication in discreet, unmarked packaging. We offer next-day delivery across the UK, with all medicines sourced from licensed UK wholesalers to guarantee authenticity. You'll receive clear administration instructions, dosing schedules, and information about potential side effects with every order.

Ongoing support is available throughout your treatment journey. Our clinical team can address questions about injection technique, side effect management, or dose adjustments. Regular follow-up assessments ensure treatment remains appropriate and effective as your weight loss progresses. All prescription medications require periodic review by a UK prescriber, which we facilitate through our online consultation platform.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. UK Public Assessment Report. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes.